Royal Bank Of Canada Biomarin Pharmaceutical Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 65,381 shares of BMRN stock, worth $4.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,381

Previous 137,843 52.57%

Holding current value

$4.36 Million

Previous $11.3 Million 59.51%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $5 Million - $6.8 Million	-72,462 Reduced 52.57%	65,381 $4.6 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $410,704 - $508,869	-5,518 Reduced 3.85%	137,843 $11.3 Million
Q1 2024 Nov 05, 2024	BUY	$83.81 - $99.0 $462,463 - $546,282	5,518 Added 4.0%	143,361 $12.5 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $1.51 Million - $1.79 Million	-18,060 Reduced 11.19%	143,361 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $185,214 - $239,379	2,430 Added 1.53%	161,421 $15.6 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $2.66 Million - $2.95 Million	-31,238 Reduced 16.42%	158,991 $14.1 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $2.18 Million - $2.52 Million	-25,117 Reduced 11.66%	190,229 $16.5 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $3.25 Million - $4.34 Million	37,035 Added 20.77%	215,346 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $956,187 - $1.28 Million	11,815 Added 7.1%	178,311 $18.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $875,332 - $1.03 Million	10,654 Added 6.84%	166,496 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $196,141 - $238,316	2,744 Added 1.79%	155,842 $12.9 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $2.66 Million - $3.32 Million	35,791 Added 30.51%	153,098 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $119,198 - $152,023	1,662 Added 1.44%	117,307 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $2.25 Million - $2.57 Million	-30,102 Reduced 20.65%	115,645 $8.94 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $11 Million - $12.4 Million	145,747 New	145,747 $12.2 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Biomarin Pharmaceutical Inc Transaction History